Home  >  Products  >  MAPT (microtubule-associated protein tau) Blocking Peptide (the middle region of MAPT)(100ug)
MAPT (microtubule-associated protein tau) Blocking Peptide (the middle region of MAPT)(100ug)

MAPT (microtubule-associated protein tau) Blocking Peptide (the middle region of MAPT)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAPT Antibody(ARP48104_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP48104
Size: 100ug
Weight: 40kDa
Gene: 4137
Format: Lyophilized powder
Target: MAPT is differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. The mutations in the gene have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
Alternative names: DDPAC; FLJ31424; FTDP-17; MAPTL; MGC138549; MSTD; MTBT1; MTBT2; PPND; TAU